Suppr超能文献

以[具体生物]为模式生物,体内鉴定转录因子诱导细胞重编程的分子障碍。 (注:原文中“by Using as a Model Organism”部分缺失具体生物名称)

Identifying Molecular Roadblocks for Transcription Factor-Induced Cellular Reprogramming In Vivo by Using as a Model Organism.

作者信息

Özcan Ismail, Tursun Baris

机构信息

Department of Biology, Institute of Cell and Systems Biology of Animals, University of Hamburg, 20146 Hamburg, Germany.

出版信息

J Dev Biol. 2023 Aug 31;11(3):37. doi: 10.3390/jdb11030037.

Abstract

Generating specialized cell types via cellular transcription factor (TF)-mediated reprogramming has gained high interest in regenerative medicine due to its therapeutic potential to repair tissues and organs damaged by diseases or trauma. Organ dysfunction or improper tissue functioning might be restored by producing functional cells via direct reprogramming, also known as transdifferentiation. Regeneration by converting the identity of available cells in vivo to the desired cell fate could be a strategy for future cell replacement therapies. However, the generation of specific cell types via reprogramming is often restricted due to cell fate-safeguarding mechanisms that limit or even block the reprogramming of the starting cell type. Nevertheless, efficient reprogramming to generate homogeneous cell populations with the required cell type's proper molecular and functional identity is critical. Incomplete reprogramming will lack therapeutic potential and can be detrimental as partially reprogrammed cells may acquire undesired properties and develop into tumors. Identifying and evaluating molecular barriers will improve reprogramming efficiency to reliably establish the target cell identity. In this review, we summarize how using the nematode as an in vivo model organism identified molecular barriers of TF-mediated reprogramming. Notably, many identified molecular factors have a high degree of conservation and were subsequently shown to block TF-induced reprogramming of mammalian cells.

摘要

通过细胞转录因子(TF)介导的重编程来生成特定细胞类型,因其在修复因疾病或创伤而受损的组织和器官方面的治疗潜力,在再生医学领域引起了高度关注。通过直接重编程(也称为转分化)产生功能性细胞,可能恢复器官功能障碍或组织功能异常。通过将体内可用细胞的身份转变为所需的细胞命运来实现再生,可能是未来细胞替代疗法的一种策略。然而,由于细胞命运保护机制限制甚至阻止起始细胞类型的重编程,通过重编程生成特定细胞类型往往受到限制。尽管如此,高效重编程以产生具有所需细胞类型适当分子和功能特性的同质细胞群体至关重要。不完全重编程将缺乏治疗潜力,并且可能有害,因为部分重编程的细胞可能获得不良特性并发展成肿瘤。识别和评估分子障碍将提高重编程效率,以可靠地建立目标细胞身份。在本综述中,我们总结了如何利用线虫作为体内模式生物来识别TF介导的重编程的分子障碍。值得注意的是,许多已识别的分子因子具有高度保守性,随后被证明会阻碍TF诱导的哺乳动物细胞重编程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a168/10531806/341aa6f305cd/jdb-11-00037-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验